Publications
- Reithmeier D, Tang-Wai R, Seifert B, Lyon A, Alcorn J, Acton B, Corley S, Prosser-Loose E, Mousseau D, Lim H, Tellez-Zenteno J, Huh L, Leung E, Carmant L, Huntsman RJ. The protocol for the Cannabidiol in Children with Refractory Epileptic Encephalopathy (CARE-E) Study: A phase 1 dosage escalation study. BMC Pediatrics. 2018; 18:221
- Huntsman RJ, Tang-Wai R, Acton B, Alcorn J, Lyon AW, Mousseau DD, Seifert B, Lapairie R, Prosser-Loose E, Hanus LO. Cannabis for the treatment of paediatric epilepsy? An update for Canadian paediatricians. Paediatr Child Health 2018
- Alaverdashvili M and Laprairie RB. The future of type 1 cannabinoid receptor allosteric ligands. Drug Metabolism Reviews 2018; 50(1) : 14-25.
- Huntsman R. et al. Cannabis for the treatment of pediatric epilepsy? An update for general pediatricians. Paediatrics & Child Health (in press)
- Bagher AM, Laprairie RB, Toguri JT, Kelly MEM, Denovan-Wright EM. Bidirectional allosteric interactions between cannabinoid receptor 1 (CB1) and dopamine receptor 2 long (D2L) heterotetramers. Eur J Pharmacol. 2017; 813: 66-83.
- Huntsman, R, Tang-Wai, R, Alcorn, J, Lyon, A, Mousseau, D, Seifert, Prosser-Loose, E, Newmeyer. CARE-E Study: CBD in Children with Refractory Epilepsy. Epilepsy Professional Magazine 2017, 46:12-17.
- Francis, R. Pediatric Epilepsy and Cannabis. Researching safe limits and tolerability. Saskatchewan Health Research Foundation, Research for Health, Oct 2017, (4): 9-12.
- BD Vacutainer® Barricor™ Blood Collection Tube is the Tube of Choice for LC-MS/MS Analysis of Bioactive Cannabinoids in Plasma. White paper 2017.
Lectures
- Laprairie R. Panelist at: INDIGENOUS INCLUSION IN THE HEMP AND CANNABIS INDUSTRIES: “Creating Sustainable Opportunities & Partnerships" Conference in Saskatoon, Mar 19/20, 2018:
- Alcorn J, Laprairie F, Sharbel T, Tanino K, Konescsni J, Phillips P. Cafe Scientifique ~Cannabinoids: Molecules, Epidemiology and Public Policy. Johnson Shoyama Centre for the Study of Science and Innovation Policy & CRIS. Univ. Sask. Mar 8, 2018.
- Laprairie R, Huntsman R. Cafe Scientifique : The Cannabinoid Research Initiative of Saskatchewan. Arts 211, Univ. Sask. Dec 1, 2017. Workshop presentation pdf
- Mousseau DD, Tang-Wai R, Huntsman R, Alcorn J. Medical Marijuana Research in Saskatchewan: From CARE-E to CRIS. Pediatric Grand Rounds, Dept Pediatrics, College of Medicine, University of Saskatchewan. April 13, 2017.
Poster Presentations
- Vuong S, Michel D, Huntsman R, Tang-Wai R, Wu F, Lyon AW, Alcorn J. Development of a LC-MS/MS assay for bioactive cannabinoids in plasma of pediatric patients on cannabis oil therapy. Applications to the Clinical Lab (MSACL) 2018 US 10th Annual Conference & Exhibits in Palm Springs, California. January 21-25, 2018.
20018 Activities & News
November 19, 2018: Legalization of Cannabis - Building Bridges Interdisciplinary Form - The Health Sciences Student's Association,. 4:45pm - Rm GB06 Health Sciences - University of Saskatchewan.
November 7, 2018: RxFiles - Academic detailing - Objective information for clinicians. New links in this website on Cannabinoids and Medical Cannabis and Medical Marijuana Patient Booklet.
September 6, 2018: Interview: Drs Robert LaPrairie and Richard Huntsman, CRIS: Research collective based at U of Sask. aiming to answer cannabis q's [CBC News]
August 16-17, 2018: Inaugural Saskatchewan Cannabinoid Research Symposium
July 12, 2018. U of S experts weigh in on cannabis legalization, On Campus News, University of Saskatchewan.
July 2, 2018. Interview: Dr. Richard Huntsman, CRIS : FDA approves first drug derived from marijuana to treat epilepsy [ Global News]
June 21, 2018: Publication: Reithmeier D, Tang-Wai R, Seifert B, Lyon AW, Alcorn J, Acton B, Corley S, Prosser-Loose E, Mousseau D, Lim H, Tellez-Zenteno J, Huh L, Leung E, Carmant L, Huntsman RJ. The protocol for the Cannabidiol in Children with Refractory Epileptic Encephalopathy (CARE-E) Study: A phase 1 dosage escalation study. BMC Pediatrics 2018; 18:221
Apr 5, 2018: Publication: Cannabis for the treatment of paediatric epilepsy? An update for Canadian paediatricians. RJ Huntsman et al.
Mar 19-20, 2018: Indigenous inclusion in the hemp and cannabis industries: “Creating Sustainable Opportunities & Partnerships" Conference in Saskatoon with Dr. R. Laprairie & staff.
Mar 8, 2018: Cafe Scientifique: Cannabinoids: Molecules, Epidemiology and Public Policy. Johnson Shoyama Centre for the Study of Science and Innovation Policy & CRIS. Univ. Sask.
Jan 21, 2018: Poster Presentation: Vuong S et al. Development of a LC-MS/MS assay for bioactive cannabinoids in plasma of pediatric patients on cannabis oil therapy. Applications to the Clinical Lab (MSACL) 2018 US 10th Annual Conference, Palm Springs, California. January 21-25, 2018.
Jan 18, 2018: Publication: The future of type 1 cannabinoid receptor allosteric ligands
Dec 19, 2017: SHRF funding approved for an "Inaugural Saskatchewan Cannabinoid Research Symposium" Dr. R. Laprairie et al in 2018. Stay tuned for details.
Dec 8, 2017: The Science of Medical Marijuana - On Campus News 25(6) p4
Dec 7, 2017: CRIS Poster at 2017 Sante Awards evening: CARE-E to CRIS. How a pilot study led to the development of a provincial research program.
Dec 1, 2017: Huntsman, Tang-Wai, Alcorn, Lyon, Mousseau, Seifert, Prosser-Loose, Newmeyer. CARE-E Study: CBD in Children with Refractory Epilepsy. Epilepsy Professional Magazine Autumn 2017.
Dec 1, 2017: Cafe Scientifique (workshop slides)